The popularity of GLP-1R drugs has catapulted the treatment landscape of obesity into the spotlight. Reformation for the ...

There’s still scope for a new generation of drugs to replace weight-loss market leaders like Novo Nordisk A/S’s Wegovy, ...

Compared with patients without obesity at the time of initial cancer diagnosis, those with obesity had lower rates of 5-year ...

A new review highlights the future of anti-obesity medications that could outperform today's already blockbuster drugs like ...

A population-based study indicates that among children with cancer, those with obesity at the time of diagnosis may face an ...

Obesity is an important health issue for patients with chronic kidney disease, speeding its progression, contributing to ...

Researchers are exploring whether microorganisms found in cow’s milk and soil can help prevent weight gain typically caused ...

Obesity at cancer diagnosis is associated with inferior survival among children aged 2 to 18 years, according to a stu ...

The changes reflect “a cultural shift” around obesity medications, said Diana Zuckerman, president of the nonprofit National ...

Obesity, which affects 650 million people worldwide, influences the development of cardiometabolic diseases and increases the risk of cancer.

In previous First Word columns, I discussed the effects of SGLT2 inhibitors on the kidney to prevent progression of chronic ...